BridgeMD
Compares treatment options for Hearing Loss
Official title WhatsApp AI Support vs Paper Support for First-Time Hearing Aid Users
ClinicalTrials.gov ID: NCT07690670
What this study is testing
- What it's testing
- The purpose of this study is to advance hearing care in low- and middle-income countries (LMICs) through the rigorous evaluation and optimization of innovative interventions and technologies. This study encompasses the following key aim: This study aims to evaluate the effectiveness of a WhatsApp-delivered AI-enabled support and acclimatization programme for adults receiving preset hearing aids in low-resource community settings.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- 18 years and older
- Confirmed mild to severe (20 to \< 80 dB PTA in both ears) hearing loss (determined during baseline assessments)
- Willing/available to commit to 5-week follow-up
- Must have access to their own personal WhatsApp
- Functional proficiency in English, isiXhosa, or Sepedi sufficient to provide informed consent and to self-complete the study outcome measures in one...
You likely can't join if
- Younger than 18 years
- Hearing loss too severe (≥80 dB HL PTA)
- Normal hearing (\<20 dB HL PTA)
- Middle ear pathology, such as otitis media, active drainage from the ears.
- Unwilling/unavailable to commit to a 5-week follow-up.
- Unilateral hearing loss
See the full eligibility criteria
- 18 years and older
- Confirmed mild to severe (20 to \< 80 dB PTA in both ears) hearing loss (determined during baseline assessments)
- Willing/available to commit to 5-week follow-up
- Must have access to their own personal WhatsApp
- Functional proficiency in English, isiXhosa, or Sepedi sufficient to provide informed consent and to self-complete the study outcome measures in one of these three languages, as judged by the recruiting CHW during the...
- Younger than 18 years
- Hearing loss too severe (≥80 dB HL PTA)
- Normal hearing (\<20 dB HL PTA)
- Middle ear pathology, such as otitis media, active drainage from the ears.
- Unwilling/unavailable to commit to a 5-week follow-up.
- Unilateral hearing loss
- No access to WhatsApp/only has access via another individual's WhatsApp
- Home language other than English, isiXhosa, or Sepedi, where the individual does not have functional proficiency in any of these three languages.
The study team makes the final eligibility decision.
Where it's taking place
- Pretoria, Province, South Africa
- Cape Town, Western Cape, South Africa
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Pretoria, Province, South Africa; Cape Town, Western Cape, South Africa. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.